Creative Planning
TYRA icon

Creative Planning’s Tyra Biosciences TYRA Stock Holding History

Creative Planning’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$696K Sell
21,803
-2,145
-9% -$71K ﹤0.01% 2932
2026
Q1 		$917K Buy
23,948
+4,345
+22% +$141K ﹤0.01% 2533
2025
Q4 		$515K Buy
+19,603
New +$360K ﹤0.01% 2816
2025
Q1 		– Sell
-63
Closed -$876 – 3725
2024
Q4 		$876 Buy
+63
New +$1.14K ﹤0.01% 3547

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Creative Planning's TYRA Position: Q2 2026 in Review

Creative Planning reduced its Tyra Biosciences (TYRA) stake by 9% in Q2 2026, selling an estimated $71K and leaving 21,803 shares worth $696K. The position accounts for ﹤0.01% of the portfolio, ranked #2932.

Creative Planning first reported a position in TYRA in Q4 2024 and has held it in 4 quarters since. The position peaked at $917K in Q1 2026. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Creative Planning held 21,803 shares of Tyra Biosciences worth $696K as of Q2 2026.
  • Creative Planning sold 2,145 Tyra Biosciences shares in Q2 2026, an estimated $71K.
  • Tyra Biosciences made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #2932 holding.
  • Creative Planning first reported a position in Tyra Biosciences in Q4 2024 and has held it in 4 quarters since.
  • Creative Planning's Tyra Biosciences position peaked at $917K in Q1 2026.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.